Search tips
Search criteria 


Logo of gutGutView this articleSubmit a manuscriptReceive email alertsContact usBMJ
Gut. 1993; 34(2 Suppl): S144–S145.
PMCID: PMC1374045

Interferon alfa-2b in mixed cryoglobulinaemia: a controlled crossover trial.


To confirm the positive results of a preliminary trial, 26 patients with mixed cryoglobulinaemia were enrolled in a controlled, randomised, crossover trial with interferon alfa-2b. A significant improvement was seen in the purpura score and alanine aminotransferase activities during six months' treatment, and was associated with a significant decrease in cryocrit and a returning to normal of the lymphocyte CD4/CD8 ratio (in eight of nine patients). No significant variations were seen during the six month period without interferon. Only six patients withdrew from treatment, three because of side effects and three because of poor compliance.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (231K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Fosella PV, Pasero G, Bombardieri S. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum. 1991 Dec;34(12):1606–1610. [PubMed]
  • Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Fosella PV, Pasero G, Bombardieri S. Antibodies against hepatitis C virus in mixed cryoglobulinemia patients. Infection. 1991 Nov-Dec;19(6):417–420. [PubMed]
  • Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Mazzoni A, Pasero G, Bombardieri S, Highfield P, et al. Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. Clin Exp Rheumatol. 1991 Nov-Dec;9(6):621–624. [PubMed]
  • Ferri C, Moriconi L, Gremignai G, Migliorini P, Paleologo G, Fosella PV, Bombardieri S. Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. Nephron. 1986;43(4):246–253. [PubMed]
  • Ferri C, Gremignai G, Bombardieri S, Moriconi L, Pontrandolfo A, Vitali C, Fosella PV, Pasero G. Plasma-exchange in mixed cryoglobulinemia. Effects on renal, liver and neurologic involvement. Ric Clin Lab. 1986 Apr-Jun;16(2):403–411. [PubMed]
  • Ferri C, Pietrogrande M, Cecchetti R, Tavoni A, Cefalo A, Buzzetti G, Vitali C, Bombardieri S. Low-antigen-content diet in the treatment of patients with mixed cryoglobulinemia. Am J Med. 1989 Nov;87(5):519–524. [PubMed]
  • Casato M, Laganà B, Antonelli G, Dianzani F, Bonomo L. Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. Blood. 1991 Dec 15;78(12):3142–3147. [PubMed]
  • Ferri C, Marzo E, Longombardo G, Lombardini F, Greco F, Bombardieri S. Alpha interferon in the treatment of mixed cryoglobulinaemia patients. Eur J Cancer. 1991;27 (Suppl 4):S81–S82. [PubMed]

Articles from Gut are provided here courtesy of BMJ Publishing Group